CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
CANADA
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Reshaping Of The Biotechnology Industry By Innovative AI Trends

Life Sciences Review | Thursday, July 14, 2022
Tweet

The biotechnology industry has progressed significantly due to AI and other computerized tools.


FREMONT, CA: Biotechnology companies and health organizations worldwide maintain massive databases. Drug manufacturing, chemical analysis of several compounds, RNA and DNA sequencing, enzyme studies, and other similar biological processes need the strong support of computerized tools and applications to increase efficiency and decrease manual errors.


Today, because of the Coronavirus pandemic. Economies are collapsing, and all hope is placed on the biotechnology industry to develop a safe, effective vaccine in the shortest possible time. Artificial intelligence is crucial in biotechnology and related applications for managing biological processes, expanding drug production, managing supply chains, and dominating the industry's data pool.


Increased and enhanced predictability for both structured and unstructured data allows businesses to plan their operations more effectively and efficiently, following in increased productivity and a faster pace of work.


These are some significant AI trends that will remodel the biotechnology industry.


Progressing Innovations: From the Laboratory to the Market


The necessity for drugs, industrial chemicals, food-grade chemicals, and other biochemistry-related raw materials has increased over the last decade. AI in biotechnology is critical for accelerating drug discovery and development (right to the point where it reaches the market). AI-based tools and apps aid develop molecule structures based on target markets.


It employs machine learning to calculate permutations and combinations of different chemicals to find the best type without manual experimentation in the lab. Predictive analysis can predict market demand for a particular drug or chemical through artificial intelligence in biotechnology. AI in biotech can also aid manage the intelligent distribution of raw materials required by the biotechnology industry.


Open-Source Artificial Intelligence Platforms: Accelerate Data Analysis


Scientists worldwide are researching AI programs that can automate data maintenance and analysis. Utilizing open-source AI programs like CRISPR libraries and H2O.ai frees lab assistants from repetitive data entry and analysis tasks.


Critical informatics tasks are also systematically examined to produce more accurate and timely results. Eliminating manual functions from healthcare providers and scientists can concentrate on innovation-driven processes allowed by biotechnology AI.


Expanding Agricultural Biotechnology's Boundaries: Enhancing Quality and Quantity


Biotechnology is critical in the development of more and better crops. AI-based tools are needed to study crop features, note and compare qualities, and forecast plausible yields.


Apart from these tools, the agricultural biotechnology industry utilizes robotics for packaging, harvesting, and other essential tasks. By compounding weather forecasts, farmland data, and the availability of seeds, manure, and pesticides, biotech AI helps plan future material movement patterns.


Weekly Brief

loading
> <
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue

Read Also

Specialized Services: A New Paradigm in Therapeutics

Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Ross Kenyon, Associate Director – Modeling, Simulation and Analysis, Regeneron Pharmaceuticals

The 7 TIPS for a Successful Master Data Migration and Ongoing Data Quality Management

Marc Jenny, Senior Director, Customer Engagement Systems & Advanced Analytics Strategy Lead, Interl. & Japan, Alexion Pharmaceuticals

The Challenges Of Bringing Phytocannabinoid Plant-Based Medicines To Market

Ron Lipsky, Vice President, Business Development & International Relations at MGC Pharmaceuticals, Ltd.

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin, Director, Infection Prevention, Tampa General Hospital

Digital Innovation

Iris Loew-Friedrich, EVP & Chief Medical Officer, UCB

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Anders Damholt, PhD Biochemistry, Head of Clinical Development Human Health Innovation & Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist, Human Health Innovation

The Rise in Outsourcing Clinical Trials

Erika Vento-Gaudens, Director, Global Clinical Trial Operations at Guardant Health
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/the-reshaping-of-the-biotechnology-industry-by-innovative-ai-trends-nwid-894.html